As researchers look for new ways to approach tough-to-treat forms of cancer, many are focusing on genetics – more specifically, they’re looking at the type of genetic tweaks found in cancerous tumors. One early-stage cancer company, Loxo Oncology, hopes to eventually sequence the tumors of its patients and use that data to find out what drugs their disease would respond best to.

Click here to read original article